ID27510A - Senyawa malimida tersubstitusi dan penggunaan farmasinya - Google Patents

Senyawa malimida tersubstitusi dan penggunaan farmasinya

Info

Publication number
ID27510A
ID27510A IDW20010409A ID20010409A ID27510A ID 27510 A ID27510 A ID 27510A ID W20010409 A IDW20010409 A ID W20010409A ID 20010409 A ID20010409 A ID 20010409A ID 27510 A ID27510 A ID 27510A
Authority
ID
Indonesia
Prior art keywords
substitutional
malimide
compounds
pharmacy use
pharmacy
Prior art date
Application number
IDW20010409A
Other languages
English (en)
Inventor
Takashi Inaba
Masahiro Tanaka
Kenji Sakoda
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of ID27510A publication Critical patent/ID27510A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW20010409A 1998-07-30 1999-07-28 Senyawa malimida tersubstitusi dan penggunaan farmasinya ID27510A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21507098 1998-07-30

Publications (1)

Publication Number Publication Date
ID27510A true ID27510A (id) 2001-04-12

Family

ID=16666269

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010409A ID27510A (id) 1998-07-30 1999-07-28 Senyawa malimida tersubstitusi dan penggunaan farmasinya

Country Status (12)

Country Link
EP (1) EP1120414A1 (id)
KR (1) KR20010085305A (id)
CN (1) CN1320123A (id)
AU (1) AU4929999A (id)
BR (1) BR9912612A (id)
CA (1) CA2338866A1 (id)
HU (1) HUP0103381A3 (id)
ID (1) ID27510A (id)
IL (1) IL141080A0 (id)
NO (1) NO20010487L (id)
PE (1) PE20000945A1 (id)
WO (1) WO2000006564A1 (id)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6719520B2 (en) 1998-10-08 2004-04-13 Smithkline Beecham Corporation Method and compounds
ES2234300T3 (es) * 1998-10-08 2005-06-16 Smithkline Beecham Plc 3-(3-cloro-4-hidroxifenilamino)-4-(2-nitrofenil)-1h-pirrol-2,5-diona como inhibidor de glucogeno cinasa-3 (gsk-3)sintetasa.
EP1224932A4 (en) * 1999-08-20 2002-10-16 Sagami Chem Res DRUGS INHIBITING CELL DEATH
GB0008264D0 (en) * 2000-04-04 2000-05-24 Smithkline Beecham Plc Novel method and compounds
YU46603A (sh) 2000-12-08 2006-05-25 Ortho-Mcneil Pharmaceutical Inc. Indazolil-supstituisana jedinjenja pirolina, kao inhibitori kinaze
AU2002336749A1 (en) * 2001-09-21 2003-04-01 Pharmacia And Upjohn Company Tricyclic indole derivatives as 5-ht ligands
TW200918046A (en) 2002-04-03 2009-05-01 Novartis Ag Indolylmaleimide derivatives
MXPA04012188A (es) 2002-06-05 2005-07-25 Johnson & Johnson Derivados de bisindolil-maleimida como inhibidores de cinasa.
EP1513520B1 (en) 2002-06-05 2008-09-24 Janssen Pharmaceutica N.V. Substituted pyrrolines as kinase inhibitors
KR20060021890A (ko) 2003-06-13 2006-03-08 얀센 파마슈티카 엔.브이. 키나제 저해제로서의 치환된 인다졸릴(인돌릴)말레이미드유도체
GB0316232D0 (en) 2003-07-11 2003-08-13 Astrazeneca Ab Therapeutic agents
MX2007005199A (es) 2004-11-01 2007-05-11 Wyeth Corp Indolizinas sustituidas y derivados como agentes del sistema nervioso central.
PT1846406E (pt) 2005-02-09 2010-12-10 Arqule Inc Derivados de maleimida, composições farmacêuticas e métodos para o tratamento do cancro
US8513292B2 (en) 2007-06-22 2013-08-20 Arqule, Inc. Compositions and methods for the treatment of cancer
CA2704282A1 (en) 2007-06-22 2008-12-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
CA2690799C (en) * 2007-06-22 2015-06-16 Arqule, Inc. Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
CN101671329B (zh) * 2009-06-17 2012-11-07 东华大学 3-氨基醇取代的吲哚马来酰亚胺化合物、其制备和应用
CN102344443A (zh) * 2011-07-15 2012-02-08 南开大学 点击化学合成开环马来酰亚胺类化合物及其在治疗疾病中的应用
WO2013029043A1 (en) * 2011-08-25 2013-02-28 Reaction Biology Corp. Selective kinase inhibitors
CN112574163B (zh) * 2021-01-29 2023-04-07 山西省肿瘤研究所 巴西苏木素类天然产物(+)-Brazilin的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4005970A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte maleinimide, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
GB9123396D0 (en) * 1991-11-04 1991-12-18 Hoffmann La Roche A process for the manufacture of substituted maleimides

Also Published As

Publication number Publication date
PE20000945A1 (es) 2000-09-25
IL141080A0 (en) 2002-02-10
NO20010487L (no) 2001-03-28
WO2000006564A1 (fr) 2000-02-10
CA2338866A1 (en) 2000-02-10
NO20010487D0 (no) 2001-01-29
CN1320123A (zh) 2001-10-31
AU4929999A (en) 2000-02-21
HUP0103381A2 (hu) 2002-02-28
EP1120414A1 (en) 2001-08-01
KR20010085305A (ko) 2001-09-07
HUP0103381A3 (en) 2002-07-29
BR9912612A (pt) 2001-11-20

Similar Documents

Publication Publication Date Title
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
ID22957A (id) Senyawa dan penggunaannya
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID27510A (id) Senyawa malimida tersubstitusi dan penggunaan farmasinya
ID24148A (id) Turunan-turunan fitostfrol dan/atau fitostanol
ID30393A (id) Senyawa tienopirimidina, pembuatan dan penggunaannya
ID28787A (id) 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya
DE69902548T2 (de) Katalysatoraktivatorverbindung
ATE357252T1 (de) Adjuvanzsysteme und impfstoffe
FI990466A0 (fi) Aktivaattorit ja laite
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
ID26599A (id) Turunan triazola dan imidazola
ID24196A (id) Komposisi dan penggunaan
ID28846A (id) 2-fenilbenzimidazol dan 2_fenilindol, pembuatan dan penggunaanya
DE69828963D1 (de) Wirstoffabgabe und gentherapiesystem
ID19824A (id) Turunan-turunan ditiolan, pembuatannya dan pengaruh terapinya
ID27667A (id) Komposisi coklat dan pemakaiannya
ID22956A (id) Sintesa disulfida dan polisulfida organik
DE69911686D1 (de) Schlüssel und Transponderträger-kombination
DE69929516D1 (de) Bremsschuh und bremse
ID26156A (id) Benzotiadiazol dan turunan-turunan
ID29052A (id) Turunan-turunan 3,3-biarilpiperidina dan 2,2-biarilmorfolina
DE69905644D1 (de) Fördermatte und Fördervorrichtung
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
ID25818A (id) Senyawa-senyawa heterosiklik, produksinya dan penggunaannya